Mar 2, 2026 07:30AM
Feb 17, 2026 07:30AM
Jan 22, 2026 12:30PM
Jan 22, 2026 12:30PM
Jan 8, 2026 07:32AM
Jan 8, 2026 07:30AM
Dec 4, 2025 07:30AM Trevi Therapeutics appoints David Hastings as chief financial officer
Dec 4, 2025 07:30AM
Nov 13, 2025 04:05PM
Nov 6, 2025 04:05PM
Nov 4, 2025 07:30AM
Oct 8, 2025 07:30AM
Sep 18, 2025 07:30AM
Sep 18, 2025 07:30AM Trevi Therapeutics Announces Two Posters from the Phase 2a RIVER Trial Data Will be Featured at the European Respiratory Society (ERS) Congress 2025
Aug 7, 2025 04:05PM
Jun 3, 2025 06:56AM
Jun 3, 2025 06:26AM
Jun 2, 2025 07:00AM
Jun 2, 2025 07:00AM
Mar 19, 2025 06:43AM
Mar 18, 2025 04:05PM Trevi Therapeutics Reports Fourth Quarter and Year End 2024 Financial Results and Provides Business Updates
Mar 10, 2025 07:13AM
Mar 10, 2025 06:22AM
Mar 10, 2025 06:00AM
Mar 6, 2025 02:04PM
Dec 3, 2024 04:06PM
Dec 3, 2024 04:05PM
Sep 30, 2024 05:42PM Trevi Therapeutics (TRVI) Appoints James V. Cassella as Chief Development Officer
Sep 30, 2024 05:30PM
May 7, 2024 04:05PM
Oct 13, 2023 08:30AM
Oct 13, 2023 08:30AM
May 11, 2023 04:05PM
Mar 16, 2023 04:05PM
Jan 5, 2023 04:05PM Trevi Therapeutics Provides Business Update Ahead of Upcoming Conferences
Nov 10, 2022 04:05PM
Sep 22, 2022 05:46PM
Sep 19, 2022 07:30AM
Sep 19, 2022 07:30AM
Sep 7, 2022 07:30AM
Aug 30, 2022 04:05PM
Aug 24, 2022 07:30AM Trevi Therapeutics Announces Multiple Late-Breaking Abstracts Accepted for Presentation at Upcoming Medical Conferences on Analysis of Oral Nalbuphine Extended Release
Aug 22, 2022 09:30AM
Aug 11, 2022 04:05PM
Aug 9, 2022 07:30AM
Aug 4, 2022 05:41PM
Jul 7, 2022 07:30AM
Jun 29, 2022 04:14PM
Jun 29, 2022 07:34AM Trevi Therapeutics (TRVI) Reports Positive Results from the Ph2b/3 PRISM Trial of Haduvio in the Treatment of Prurigo Nodularis
Jun 29, 2022 07:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All